|Articles|April 5, 2023
Pharma USA 2023: IRA Impact on Patients
Advertisement
Kevin Hagan, president and CEO of the PAN Foundation, participated on the Pharma USA 2023 panel "Post-Inflation Reduction Act: The continued need for patient assistance." Here he speaks to Pharmaceutical Executive about the IRA's impact on Medicare patients' affordability.
Advertisement
Related Content
Advertisement
President Trump Announces Phased Generic Drug Tariff Plan: Report
Published: | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
2
argenx Acquires Forte Biosciences for $2.2 Billion
3
Where the True Bottlenecks Exist at FDA for Clinical Trials
4
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
5